Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Research Article

In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicidal Ideation and Substance Use Disorder

Author(s): Alireza Sharafshah, Kai-Uwe Lewandrowski, Mark S. Gold, Brian Fuehrlein, John Wesson Ashford, Panayotis K. Thanos, Gene Jack Wang, Colin Hanna, Jean Lud Cadet, Eliot L. Gardner, Jag H. Khalsa, Eric R. Braverman, David Baron, Igor Elman*, Catherine A. Dennen, Abdalla Bowirrat, Albert Pinhasov, Edward J. Modestino, Paul R. Carney, Rene Cortese, Rossano Kepler Alvim Fiorelli, Sergio Schmidt, Aryeh R. Pollack, Rajendra D. Badgaiyan and Kenneth Blum*

Volume 23, Issue 8, 2025

Published on: 24 January, 2025

Page: [974 - 995] Pages: 22

DOI: 10.2174/011570159X349579241231080602

open_access

Abstract

Introduction: Glucagon-Like Peptide-1 Receptor (GLP1R) agonists have become widespread anti-obesity/diabetes pharmaceuticals in the United States.

Aim: This article aimed to provide our current knowledge on the plausible mechanisms linked to the role of Ozempic (Semaglutide), which is generalized as one of the anti-addiction compounds.

Methods: The effects of GLP1R agonists in Alcohol Use Disorder (AUD) and substance use disorder (SUD) are mediated, in part, through the downregulation of dopamine signaling. We posit that while GLP1R agonism could offer therapeutic advantages in hyperdopaminergia, it may be detrimental in patients with hypodopaminergia, potentially leading to long-term induction of Suicidal Ideation (SI). The alleged posit of GLP1 agonists to induce dopamine homeostasis is incorrect. This study refined 31 genes based on the targets of Ozempic, GLP1R, and related enzymes for SI and 10 genes of the Genetic Addiction Risk Score (GARS) test. STRING-MODEL refined 29 genes, and further primary analyses indicated associations of GLP1R with DRD3, BDNF, CREB1, CRH, IL6, and DPP4.

Results: In-depth silico enrichment analysis revealed an association between candidate genes and depressive phenotypes linked with dopaminergic signaling. Finally, through primary and in-depth silico analyses, we demonstrated multiple findings supporting that GLP1R agonists can induce depression phenotypes.

Conclusion: Our findings suggest that associated polymorphisms seem to have overlapping effects with addictive behaviors of Reward Deficiency Syndrome (RDS) and dopamine regulation. Consequently, GLP1R agonists may represent a double-edged sword, potentially triggering both antiaddictive effects and SI by exacerbating depressive phenotypes. Thus, we encourage the scientific community to perform further empirical clinical studies to confirm this proposed pathway.

Keywords: GLP1, Ozempic, suicide ideation, substance use disorder, dopamine homeostasis, in-depth in silico.

« Previous
[1]
Abuse, S.; Administration, M.H.S. Key substance use and mental health indicators in the United States: Results from the 2018 National survey on drug use and health., 2019. Available from: https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHNationalFindingsReport2018/NSDUHNationalFindingsReport2018.htm
[2]
Organization, W.H. Global status report on road safety 2018; World Health Organization, 2019.
[3]
Kohn, R.; Saxena, S.; Levav, I.; Saraceno, B. The treatment gap in mental health care. Bull. World Health Organ., 2004, 82(11), 858-866.
[PMID: 15640922]
[4]
Dahlgren, A.; Wargelius, H.L.; Berglund, K.J.; Fahlke, C.; Blennow, K.; Zetterberg, H.; Oreland, L.; Berggren, U.; Balldin, J. Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A pilot study. Alcohol Alcohol., 2011, 46(5), 509-513.
[http://dx.doi.org/10.1093/alcalc/agr045] [PMID: 21613303]
[5]
Crime., U.N.O.o.D.a., World Drug Report 2023; United Nations: New York, NY, 2023.
[6]
Organization, W.H. WHO global report on trends in prevalence of tobacco use 2000-2030; World Health Organization, 2024.
[7]
Dai, X.; Gakidou, E.; Lopez, A.D. Evolution of the global smoking epidemic over the past half century: Strengthening the evidence base for policy action. Tob. Control, 2022, 31(2), 129-137.
[http://dx.doi.org/10.1136/tobaccocontrol-2021-056535] [PMID: 35241576]
[8]
WHO Report on GLOBAL TOBACCO Epidemic; 2023; Protect people for tobacco smoke. WHO 2023.
[9]
Howes, O.D.; Kapur, S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr. Bull., 2009, 35(3), 549-562.
[http://dx.doi.org/10.1093/schbul/sbp006] [PMID: 19325164]
[10]
Klausen, M.K.; Thomsen, M.; Wortwein, G.; Fink-Jensen, A. The role of glucagon-like peptide 1 (GLP-1) in addictive disorders. Br. J. Pharmacol., 2022, 179(4), 625-641.
[http://dx.doi.org/10.1111/bph.15677] [PMID: 34532853]
[11]
Zhang, X.; Belousoff, M.J.; Zhao, P.; Kooistra, A.J.; Truong, T.T.; Ang, S.Y.; Underwood, C.R.; Egebjerg, T.; Šenel, P.; Stewart, G.D. Differential GLP-1R binding and activation by peptide and non-peptide agonists. Mol. Cell, 2020, 80(3), 485-500.
[12]
Volkow, N.D.; Wise, R.A.; Baler, R. The dopamine motive system: Implications for drug and food addiction. Nat. Rev. Neurosci., 2017, 18(12), 741-752.
[http://dx.doi.org/10.1038/nrn.2017.130] [PMID: 29142296]
[13]
Blum, K.; Kozlowski, G. Ethanol and neuromodulator interactions: A cascade model of reward. In: Alcohol and Behavior; VSP Press, 1990, pp. 131-149.
[14]
Rebosio, C.; Balbi, M.; Passalacqua, M.; Ricciarelli, R.; Fedele, E. Presynaptic GLP-1 receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus. Biofactors, 2018, 44(2), 148-157.
[http://dx.doi.org/10.1002/biof.1406] [PMID: 29265673]
[15]
Brodnik, Z.D.; Batra, A.; Oleson, E.B.; España, R.A. Local GABAA receptor-mediated suppression of dopamine release within the nucleus accumbens. ACS Chem. Neurosci., 2019, 10(4), 1978-1985.
[http://dx.doi.org/10.1021/acschemneuro.8b00268] [PMID: 30253088]
[16]
Chuong, V.; Farokhnia, M.; Khom, S.; Pince, C.L.; Elvig, S.K.; Vlkolinsky, R.; Marchette, R.C.N.; Koob, G.F.; Roberto, M.; Vendruscolo, L.F.; Leggio, L. The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission. JCI Insight, 2023, 8(12), e170671.
[http://dx.doi.org/10.1172/jci.insight.170671] [PMID: 37192005]
[17]
Andreadis, P.; Karagiannis, T.; Malandris, K.; Avgerinos, I.; Liakos, A.; Manolopoulos, A.; Bekiari, E.; Matthews, D.R.; Tsapas, A. Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Obes. Metab., 2018, 20(9), 2255-2263.
[http://dx.doi.org/10.1111/dom.13361] [PMID: 29756388]
[18]
Htike, Z.Z.; Zaccardi, F.; Papamargaritis, D.; Webb, D.R.; Khunti, K.; Davies, M.J. Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis. Diabetes Obes. Metab., 2017, 19(4), 524-536.
[http://dx.doi.org/10.1111/dom.12849] [PMID: 27981757]
[19]
Gerstein, H.C.; Colhoun, H.M.; Dagenais, G.R.; Diaz, R.; Lakshmanan, M.; Pais, P.; Probstfield, J.; Riesmeyer, J.S.; Riddle, M.C.; Rydén, L.; Xavier, D.; Atisso, C.M.; Dyal, L.; Hall, S.; Rao-Melacini, P.; Wong, G.; Avezum, A.; Basile, J.; Chung, N.; Conget, I.; Cushman, W.C.; Franek, E.; Hancu, N.; Hanefeld, M.; Holt, S.; Jansky, P.; Keltai, M.; Lanas, F.; Leiter, L.A.; Lopez-Jaramillo, P.; Cardona Munoz, E.G.; Pirags, V.; Pogosova, N.; Raubenheimer, P.J.; Shaw, J.E.; Sheu, W.H.H.; Temelkova-Kurktschiev, T.; Abella, M.; Alebuena, A.; Almagro, S.; Amoroso, E.; Anadon, P.; Andreu, E.; Aristimuño, G.; Arzadun, M.; Barbieri, M.; Barcudi, R.; Bartolacci, I.; Bolobanich, G.; Bordonava, A.; Bustamante Labarta, M.; Bustos, B.; Caccavo, A.; Camino, A.; Cantero, M.; Carignano, M.; Cartasegna, L.; Cipullo, M.; Commendatore, V.; Conosciuto, V.; Costamagna, O.; Crespo, C.; Cuello, J.; Cuneo, C.; Cusimano, S.; Dean, S.; Dituro, C.; Dominguez, A.; Farah, M.; Fernandez, A.; Fernandez, F.; Ferrari, A.; Flammia, P.; Fuentealba, J.; Gallardo, K.B.; Garcia, C.; Garcia, D.R.; Garrido, M.; Gavicola, R.; Gerbaudo, C.; Gilli, G.; Giotto, A.P.; Godoy Bolzán, P.; Gomez Vilamajo, O.; Guerlloy, F.; Guridi, C.; Gutierrez Garrido, N.; Hasbani, E.; Hermida, S.; Hominal, M.; Hrabar, A.; Ingaramo, A.; Izzicupo, A.; Krynski, M.; Lagrutta, M.; Lanchiotti, P.; Langhe, M.; Leonard, V.; Llanos, J.; Lopez Santi, R.; Lowenstein, J.; Luquez, C.; Mackinnon, I.; Mana, M.; Manzur, S.; Marino, J.; Martella, C.; Martinez, R.; Matias, R.; Matkovich, J.; Meritano, M.; Montaña, O.; Mulazzi, M.; Ochoa, J.; Paterlini, G.; Pelagagge, M.; Peralta Lopez, M.E.; Prado, A.; Pruyas, L.; Racca, M.; Ricotti, C.; Rodriguez, C.; Romero Vidomlansky, M.; Ronderos, R.; Sadowski, A.L.; Sala, J.; Sánchez, A.; Santoro, A.; Schiavi, L.; Sein, M.; Sernia, V.; Serra, L.; Sicer, M.; Smith, T.; Soso, L.; Sposetti, G.; Steinacher, A.; Stival, J.; Tedesco, J.; Tonin, H.; Tortolo, M.; Ulla, M.; Vallejos, J.; Vico, M.; Virgillito, L.; Visco, V.; Vogel, D.; Waisman, F.; Zaidman, C.; Zucchiatti, N.; Badshah, I.; Cohen, N.; Colman, P.; Colquhoun, D.; Davis, T.; Fourlanos, S.; Fulcher, G.; Hamlyn, J.; Haywood, C.; Hocking, S.; Huchinson, M.; Jeffries, W.; Kyl, M.; Lo, C.; Mah, P.M.; Makepeace, A.; Marope, D.; Nanayakkar, N.; Nankervis, A.; Palmer, N.; Palolus, B.; Pillai, S.; Price, S.; Price, S.; Proietto, J.; Reutens, A.; Rodrigo, N.; Sheikh, A.; Smith, G.; So, M.; Soldatos, G.; Stuckey, B.; Sumithran, P.; Teede, H.; Vora, P.; Williams, L.; Abib, E.; Adão Poço, C.; Alves, É.F.; Andreatta Bernardi Barea, J.; Avezum Oliveira, L.; Castro, D.L.C.; Correa da Cruz, I.; Costa, M.; Cruz, I.; Cunha, S.; Da Silva, M.A.V.; de Carvalho Camara Bona, R.; de Paula, B.; Eliaschewitz, F.; Fazolli, G.; Ferreira Filho, C.A.; Fortes, J.; França, C.; Franco, D.R.; Genestreti, P.R.; Giorgeto, F.; Gonçalves, R.M.; Grossman, M.E.; Henrique Marcelino, A.C.; Hernandes, M.; Horta, A.; Jaeger, C.; Kaneblai, M.; Kauffman Rutenberg, C.; Kerr Saraiva, J.F.; Lemos, M.A.; Maia, L.; Manenti, E.R.; Marques, M.; Melissa Valerio, C.; Moreira, R.; Mothé, F.; Mouco, O.M.; Moura, P.; Moura Jorge, J.C.; Nakashima, C.; Nakazone, M.; Napoli, T.; Nunes, C.; Nunes Salles, J.E.; Oliveira, K.; Oliveira, M.; Pantano, G.S.; Petri, F.; Piazza, L.; Pires, A.C.; Pizzato, P.; Prata, S.; Precoma, D.; Rech, R.; Reis, G.; Reis, H.; Resende, E.; Ribas Fortes, J.; Rodovalho, S.; Rossi dos Santos, F.; Salles, J.E.; Sampaio, C.R.; Santos, T.; Santos dos Santos, V.; Silva e Quadros, T.; Silveira, D.; Siqueira, K.N.; Teireira, M.; Uehara, M.; Valerio, C.; Vianna, H.; Vidotti, M.H.; Visconti, G.L.; Zanella, M.T.; Andreeva, V.; Borisov, R.; Botushanov, N.; Dimitrov, G.; Dimova, K.; Dragoychev, T.; Grigorova, V.; Gushterova, V.; Ivanov, I.; Kocelova, T.; Kurktschiev, D.; Miletieva, M.; Nenkova-Gugusheva, N.; Pancheva, R.; Pavlova, M.; Raev, D.; Spasova, V.; Stoikov, A.; Troev, D.; Yanev, T.; Yoncheva-Mihaylova, M.; Abitbol, A.; Ajala, B.; Alguwaihes, A.; Ardilouze, J-L.; Aris-Jilwan, N.; Arnaout, A.; Aronson, R.; Aslam, N.; Babin, S.; Bailargeon, J-P.; Bailey, A.; Bajaj, H.; Beauchesne, C.; Beca, S.; Belanger, A.; Bell, A.; Bellabarba, D.; Berard, L.; Berenbaum, B.; Bergeron, V.; Berlingieri, J.; Bernier, F.; Bishara, P.; Blank, D.; Blumer, I.; Brault, S.; Breton, D.; Carpentier, A.; Cha, J.; Chandra, P.; Chiasson, J-L.; Conway, J.R.; Couture, G.; Couture, N.; Dagenais, G.; Datta, D.; D’Ignazio, G.; Dumas, R.; Fay, D.; Frechette, A.; Frenette, L.; Fung, D.; Gagnon, N.; Galter, M.; Garon, J.; Gauthier, J.S.; Geadah, C.; Gilbert, J.; Girard, R.; Goldenberg, R.; Grossman, L.D.; Gupta, N.; Halle, J-P.; Hivert, M-F.; Houde, G.; Houlden, R.; Hramiak, I.; Jablonski, T.; Jain, A.J.; Khandwala, H.; Khosla, M.; Lachance, C.; Laflamme, E.; Langlois, M-F.; Larivee, L.; Liutkus, J.; Lochnan, H.; Malik, S.; McDonald, C.; Mehta, P.; Mihailidis, J.; Milot, A.; Narula, P.; Nault, P.; Nayar, A.; Nisker, W.; Ouellet, G.; Palardy, J.; Patel, M.; Paul, T.; Pedersen, S.; Perron, P.; Pesant, M-H.; Poirier, P.; Poulin, M-C.; Punthakee, Z.; Rehman, W.; Ross, S.; Sagar, P.; Saliba, N.; Sandler, S.; Schiffrin, A.; Schlosser, R.; Seth-Sharma, A.; Sherman, M.; Sionit, D.; Sivakumar, T.; Soto, J.; St-Amour, E.; Steen, O.; Sussman, J.; Telner, A.; Tobe, S.; Twum-Barima, D-Y.; Van Zanten, A.; VanRossum, N.; Vecchiarelli, J.; Ward, R.; Wessengel, J.; Weisnagel, S.; Wilderman, I.; Woo, V.; Yakubovich, N.; Yale, J-F.; Yared, Z.; Acevedo, M.; Aguirre, M.L.; Aizman, A.; Barroso, M.S.; Cobos, L.; Danin Vargas, A.; Descalzi, B.; Godoy, G.; Grumberg, E.; Lahsen, R.; Larenas, G.; Ortiz, E.; Paredes, J.; Potthoff, S.; Retamal, E.; Rojas, L.; Salgado, M.; Santibanez, C.; Solis, C.; Stokins, B.; Accini, J.; Acebedo, J.; Agudelo Baena, L.M.; Alarcon, S.; Angel, J.; Arcos, E.; Aroca Martinez, M.; Atuesta, L.; Balaguera, J.; Ballestas, D.; Barrera, S.I.; Barrios Reyes, R.; Bayona, A.; Bermudez, A.; Bernal, D.Z.; Blanquicett, M.; Bravo, V.; Bueno, W.; Burbano Delgado, A.; Cadena, A.; Cadena, A.; Caicedo, S.; Celemin, C.; Consuegra, R.; Contreras Pimienta, C.; Corredor, K.J.; Cure, C.; De La Hoz Rueda, L.D.; Delgado, E.; Diaz, S.; Diego, M.; Donado, A.; Encinales Sanabria, W.; Escobar, J.; Escorcia, G.; Forero, L.; Fuentes, L.; Garcia, M.; Garcia Lozada, H.; Garcia Ortiz, L.; Giraldo, A.; Gomez Gonzalez, L.; Granada, J.; Gutierrez, C.; Henao, N.; Hernandez, E.; Herrera Uejbe, O.M.; Higuera Cobos, J.D.; Ibarra Gómez, J.; Jaimes, E.H.; Jaramillo, M.; Jaramillo, N.; Jaramillo Gomez, C.; Jaramillo Sanchez, M.; Jarava Durán, I.; Lopez Ceballos, C.; Madrid, C.; María Amastha, E.; Mercado, J.; Molina, D.I.; Molina Soto, J.; Montoya, C.; Morales, A.; Muñoz, C.; Orozco, L.A.; Osorio, O.; Palmera Sanchez, J.M.; Peña, A.; Perez, J.; Perez Agudelo, J.; Pérez Amador, G.; Pertuz, C.; Posada, I.; Puerta, C.; Quintero, A.; Quiroz, D.; Rendon, C.; Reyes, A.; Reyes, A.; Ripoll, D.; Rivera, C.; Rocha, M.; Rodriguez, J.F.; Rodriguez Villanueva, K.A.; Rodriguez Zabala, J.E.; Rojas, S.; Romero, M.; Rosero, R.; Rosillo Cardenas, A.R.; Rueda, L.; Sanchez, G.; Sanchez, T.; Sotomayor Herazo, A.; Suarez, M.; Torres, M.; Trujillo, F.; Urina, M.; Van Strahlen, L.; Velandia, C.; Velasquez Guzman, C.; Velazquez, E.; Vidal Prada, T.; Yepez Alvaran, J.P.; Zarate, D.; Andelova, J.; Benesova, R.; Buzova, B.; Cech, V.; Chodova, I.; Choura, M.; Dufka, A.; Gamova, A.; Gorgol, J.; Hala, T.; Havlova, H.; Hlavkova, D.; Horanska, P.; Ilcisin-Valova, J.; Jenickova, P.; Jerabek, O.; Kantorova, I.; Kolomaznikova, K.; Kopeckova, I.; Kopeckova, M.; Linhart, K.; Linhart, T.; Malecha, J.; Malicherova, E.; Neubauerova, D.; Oznerova, M.; Partys, R.; Pederzoliova, E.; Petrusova, M.; Prymkova, V.; Racicka, E.; Reissova, I.; Roderova, E.; Stanek, L.; Striova, A.; Svarcova, D.; Svoboda, P.; Szeghy Malicharova, E.; Urge, J.; Vesely, L.; Wasserburger, B.; Wasserburgerova, H.; Zahumensky, E.; Zamrazil, V.; Alawi, H.; Anastasiadis, E.; Axthelm, E.; Bieler, T.; Buhrig, C.; Degtyareva, E.; Dellanna, F.; Derwahl, K-M.; Diessel, S.; Dogiami, B.; Dorn-Weitzel, K.; Ernst, M.; Faulmann, G.; Fetscher, B.; Forst, T.; Freyer-Lahres, G.; Funke, K.; Ganz, X.; Gleixner, C.; Hanefeld, C.; Heinrichs, S.; Helleberg, S.; Henkel, E.; Hetzel, G.R.; Hoffmann, C.; Jacob, F.; Jacob, S.; John, F.; Jonczyk, A.; Kamke, W.; Klein, C.; Kleinhardt, M.; Kleophas, W.; Kosch, C.; Kreutzmann, K.; Kühn, A.; Lee-Barkey, Y.H.; Lier, A.; Maatouk, S.; Minnich, J.; Mitry, M.; Muessig, I.; Nicula, D.; Niemann, M.; Nothroff, J.; Ott, P.; Pfuetzner, A.; Pfützner, A.; Pistrosch, F.; Pohl, W.; Prochazkova, Z.; Retkowska, M.; Rosin, H.; Sachsenheimer, D.; Samer, H.; Sanuri, M.; Schaefer, A.; Schaper, F.; Schulze, E-D.; Schulze, M.; Schumann, M.; Segiet, T.; Sowa, V.; Stahl, H-D.; Steinfeldt, F.; Teige, M.; Trieb, B.; Tschoepe, D.; Uebel, P.; Warken, B.; Weigmann, I.; Weyland, K.; Wilhelm, K.; Balo, T.; Balsay, M.; Bende, I.; Bezzegh, K.; Birkus, Z.; Buday, B.; Csomai, M.; Deak, L.; Dezso, E.; Faludi, P.; Faluvegi, M.; Fazekas, I.; Feher, A.; Fejer, C.; Finta, E.; Fulcz, A.; Gaal, Z.; Gurzo, M.; Hati, K.; Herczeg, G.; Jozsef, I.; Juhasz, M.; Keltai, K.; Koranyi, L.; Kulcsar, E.; Kun, K.; Laczko, A.; Literáti-Nagy, B.; Mezo, I.; Mileder, M.; Moricz, I.; Nagy, K.; Nagybaczoni, B.; Nemeth, C.; Oze, A.; Pauer, J.; Peterfai, E.; Polocsanyi, B.; Poor, F.; Reiber, I.; Salamon, C.; Sebestyen, J.; Torok, I.; Tuu, M.; Varga, A.; Vass, V.; Ahn, C.M.; Ahn, C. ByungWon, P.; Chang, H-J.; Chang, K.; Choi, E-Y.; Choi, H.S.; Chung, J-W.; Hong, B-K.; Hong, Y.J.; Hyon, M.S.; Jeong, M.H.; Kang, S.; Kim, B-K.; Kim, J-H.; Kim, J.H.; Kim, K-S.; Kim, K-S.; Kim, M.H.; Kim, P-J.; Kim, S-K.; Kim, Y-S.; Kim, Y.K.; Koh, Y.S.; Kwon, H.M.; Lee, B.K.; Lee, B-W.; Lee, J.B.; Lee, M-M.; Lim, Y-M.; Min, P.K.; Park, J.S.; Park, J.; Park, K.H.; Park, S.; Pyun, W.B.; Rim, S.J.; Ryu, D-R.; Seo, H-S.; Seung, K.B.; Shin, D-H.; Sim, D.S.; Yoon, Y.W.; Andersone, I.; Babicka, K.; Balcere, I.; Barons, R.; Capkovska, I.; Geldnere, K.; Grigane, I.; Jegere, B.; Lagzdina, I.; Mora, L.; Pastare, S.; Ritenberga, R.; Romanova, J.; Saknite, I.; Sidlovska, N.; Sokolova, J.; Steina, S.; Strizko, I.; Teterovska, D.; Vizina, B.; Barsiene, L.; Belozariene, G.; Daugintyte-Petrusiene, L.; Drungiliene, N.; Garsviene, N.; Grigiene, A.; Grizas, V.; Jociene, V.; Kalvaitiene, D.; Kaupiene, J.; Kavaliauskiene, J.; Kozloviene, D.; Lapteva, I.; Maneikiene, B.; Marcinkeviciene, J.; Markauskiene, V.; Meiluniene, S.; Norkus, A.; Norviliene, R.; Petrenko, V.; Radzeviciene, R.; Sakalyte, G.; Urbonas, G.; Urbutiene, S.; Vasiliauskas, D.; Velickiene, D.; Aguilar, C.; Alcocer, M.; Avalos-Ramirez, J.A.; Banda-Elizondo, R.; Bricio-Ramirez, R.; Cardenas, M.K.; Cavazos, F.; Chapa, J.; Cienfuegos, E.; De la Peña, A.; de la Peña Topete, G.; De los Rios Ibarra, M.O.; Elias, D.; Flores-Moreno, C.; Garcia, H.P.; Gonzalez, L.G.; Guerra Moya, R.L.; Guerra-Lopez, A.; Hernandez, B.R.; Herrera, C.C.; Herrera-Marmolejo, M.; Islas-Palacios, N.; Lopez, E.; Lopez, F.; Lopez, A.A.; Luna, C.R.I.; Morales, V.E.; Moreno-Virgen, G.; Parra Perez, R.L.; Pascoe, G.S.; Peralta-Cantu, I.; Previn, R.; Ramirez, R.; Ramirez, R.; Ramos, Z.M.G.; Rodriguez, M.; Salgado-Sedano, R.; Sanchez-Aguilar, A.C.; Santa Rosa Franco, E.; Sauque-Reyna, L.; Suarez Otero, R.; Torres, I.; Velarde-Harnandez, E.; Villagordoa, J.; Villeda-Espinoza, E.; Vital-Lopez, J.; Zavala- Bello, C.J.; Baker, J.; Barrington-Ward, E.; Brownless, T.; Carroll, R.; Carson, S.; Choe, M.; Corin, A.; Corley, B.; Cutfield, R.; Dalaman, N.; Dixon, P.; Drury, P.; Dyson, K.; Florkowski, C.; Ford, M.; Frengley, W.; Helm, C.; Katzen, C.; Kerr, J.; Khanolkar, M.; Kim, D.; Koops, R.; Krebs, J.; Leikis, R.; Low, K.; Luckey, A.; Luke, R.; Macaulay, S.; Marks, R.; McNamara, C.; Millar-Coote, D.; Miller, S.; Mottershead, N.; Reid, J.; Robertson, N.; Rosen, I.; Rowe, D.; Schmiedel, O.; Scott, R.; Sebastian, J.; Sheahan, D.; Stiebel, V.; Ternouth, I.; Tofield, C.; Venter, D.; Williams, M.; Williams, M.; Wu, F.; Young, S.; Arciszewska, M.; Bochenek, A.; Borkowski, P.; Borowy, P.; Chrzanowski, T.; Czerwinski, E.; Dwojak, M.; Grodzicka, A.; Janiec, I.; Jaruga, J.; Jazwinska-Tarnawska, E.K.; Jedynasty, K.; Juzwiak-Czapiewska, D.; Karczewicz-Janowska, J.; Konieczny, J.; Konieczny, M.; Korol, M.; Kozina, M.; Krzyzagorska, E.; Kucharczyk-Petryka, E.; Laz, R.; Majchrzak, A.; Mrozowska, Z.; Mularczyk, M.; Nowacka, E.; Peczynska, J.; Petryka, R.; Pietrzak, R.; Pisarczyk-Wiza, D.; Rozanska, A.; Ruzga, Z.; Rzeszotarska, E.; Sacha, M.; Sekulska, M.; Sidorowicz-Bialynicka, A.; Stasinska, T.; Strzelecka-Sosik, A.; Swierszcz, T.; Szymkowiak, K.M.; Turowska, O.; Wisniewska, K.; Wiza, M.; Wozniak, I.; Zelazowska, K.; Ziolkowska-Gawron, B.; Zytkiewicz-Jaruga, D.; Albota, A.; Alexandru, C.; Avram, R.; Bala, C.; Barbonta, D.; Barbu, R.; Braicu, D.; Calutiu, N.; Catrinoiu, D.; Cerghizan, A.; Ciorba, A.; Craciun, A.; Doros, R.; Duma, L.; Dumitrache, A.; Ferariu, I.; Ferician Moza, A.; Ghergan, A.; Ghise, G.; Graur, M.; Gribovschi, M.; Mihai, B.; Mihalache, L.; Mihalcea, M.; Mindrescu, N.; Morosanu, M.; Morosoanu, A.; Mota, M.; Moza, A.; Nafornita, V.; Natea, N.; Nicodim, S.; Nita, C.; Onaca, A.; Onaca, M.; Pop, C.; Pop, L.; Popa, A.; Popescu, A.; Pruna, L.; Roman, G.; Rosu, M.; Sima, A.; Sipciu, D.; Sitterli-Natea, C.N.; Szilagyi, I.; Tapurica, M.; Tase, A.; Tutescu, A-C.; Vanghelie, L.; Verde, I.; Vlad, A.; Zarnescu, M.; Akhmetov, R.; Allenova, I.; Avdeeva, I.; Baturina, O.; Biserova, I.; Bokovin, N.; Bondar, I.; Burova, N.; Chufeneva, G.; Chumachek, E.; Demidova, M.; Demin, A.; Drobysheva, V.; Egorova, I.; Esenyan, L.; Gelig, E.; Gilyarevsky, S.; Golshmid, M.; Goncharov, A.; Gorbunova, A.; Gordeev, I.; Gorelysheva, V.; Goryunova, T.; Grebenshchikova, I.; Ilchenko, R.; Ivannikova, M.; Karabalieva, S.; Karpeeva, J.; Khaykina, E.; Kobalava, Z.; Kononenko, I.; Korolik, O.; Korshunova, A.; Kostenko, V.; Krasnopevtseva, I.; Krylova, L.; Kulkova, P.; Kuzmina, I.; Ledyaeva, A.; Levashov, S.; Lokhovinina, N.; Lvov, V.; Martirosyan, N.; Nedogoda, S.; Nilk, R.; Osmolovskaya, Y.; Panov, A.; Paramonova, O.; Pavlova, E.; Pekareva, E.; Petunina, N.; Ponamareva, S.; Reshedko, G.; Salasyuk, A.; Sepkhanyan, M.; Serebrov, A.; Shabelnikova, O.; Skvortsov, A.; Smirnova, O.; Spiridonova, O.; Strogova, S.; Taratukhin, E.; Tereschenko, S.; Trukhina, L.; Tsarkova, O.; Tsoma, V.; Tumarov, F.; Tyan, N.; Tyurina, T.; Villevalde, S.; Yankovaya, E.; Zarutskaya, L.; Zenkova, E.; Badat, A.; Bester, F.; Blignaut, S.; Blom, D.; Booysen, S.; Boyd, W.; Brice, B.; Brown, S.; Burgess, L.; Cawood, R.; Coetzee, K.; Conradie, H.; Cronje, T.; de Jong, D.; Ellis, G.; Emanuel, S.; Engelbrecht, I.; Foulkes, S.; Fourie, D.; Gibson, G.; Govender, T.; Hansa, S.; Hemus, A.C.; Hendricks, F.; Heradien, M.; Holmgren, C.; Hoosain, Z.; Horak, E.; Howard, J.; Immink, I.; Janari, E.; Jivan, D.; Klusmann, K.; Labuschagne, W.; Lai, Y.; Latiff, G.; Lombaard, J.; Lottering, H.; Meeding, R.; Middlemost, S.; Mitha, H.; Mitha, I.; Mkhwanazi, S.; Moodley, R.; Murray, A.; Musungaie, D.; Osman, Y.; Peacey, K.; Pillay-Ramaya, L.; Pretorius, C.; Prozesky, H.; Sarvan, M.; Scholtz, E.; Sebesteny, A.; Skinner, B.; Skriker, M.; Smit, M.; Stapelberg, A-M.; Swanepoel, N.; Urbach, D.; van Aswegen, D.; van Zyl, F.; Van Zyl, L.; Venter, E.; Wadvalla, S.; Wing, J.; Wolmarans, K.; Abreu, C.; Aguilà, P.; Aguilera, E.; Alonso, N.; Alvarez, C.; Cajas, P.; Castro, J.C.; Codinachs, R.; Contreras, J.; Coves, M.J.; Fajardo, C.; Ferrer, J.C.; Font, N.; Garcia, M.; Gil, M.A.; Gomez, F.; Gomez, L.A.; Gonzalbez, J.; Griera, J.L.; Masmiquel, L.; Mauricio, D.; Narejos Perez, S.; Nicolau, J.A.; Noheda Contreras, O.; Olivan, J.; Olivares, J.; Ortega, E.; Pellitero, S.; Pertusa, S.; Rius, F.; Rodriguez, I.; Sánchez-Juan, C.; Santos, D.; Soldevila, B.; Subias, D.; Terns, M.; Trescoli, C.; Vilaplana, J.; Villanueva, A.; Albo, J.; Antus, K.; Axelsson, M.; Bergström, L.; Binsell-Gerdin, E.; Boman, K.; Botond, F.; Dotevall, A.; Graipe, A.; Jarnet, C.; Kaminska, J.; Kempe, A.; Korhonen, M.; Linderfalk, C.; Liu, B.; Ljungstroem, K.; Ljungström, K.; Malmqvist, L.; Mellbin, L.; Mooe, T.; Nicol, P.; Norrby, A.; Ohlsson, A.; Rosengren, A.; Saaf, J.; Salmonsson, S.; Strandberg, O.; Svensson, K-A.; Tengmark, B-O.; Tsatsaris, G.; Ulvenstam, A.; Vasko, P.; Chang, C-T.; Chang, H-M.; Chen, J-F.; Chen, T-P.; Chung, M-M.; Fu, C-P.; Hsia, T-L.; Hua, S-C.; Kuo, M-C.; Lee, C.; Lee, I-T.; Liang, K-W.; Lin, S.Y.; Lu, C-H.; Ma, W-Y.; Pei, D.; Shen, F-C.; Su, C-C.; Su, S-W.; Tai, T-S.; Tsai, W-N.; Tsai, Y-T.; Tung, S-C.; Wang, J-S.; Yu, H-I.; Al-Qaissi, A.; Arutchelvam, V.; Atkin, S.; Au, S.; Aye, M.M.; Bain, S.; Bejnariu, C.; Bell, P.; Bhatnagar, D.; Bilous, R.; Black, N.; Brennan, U.; Brett, B.; Bujanova, J.; Chow, E.; Collier, A.; Combe, A.; Courtney, C.; Courtney, H.; Crothers, J.; Eavis, P.; Elliott, J.; Febbraro, S.; Finlayson, J.; Gandhi, R.; Gillings, S.; Hamling, J.; Harper, R.; Harris, T.; Hassan, K.; Heller, S.; Jane, A.; Javed, Z.; Johnson, T.; Jones, S.; Kennedy, A.; Kerr, D.; Kilgallon, B.; Konya, J.; Lindsay, J.; Lomova-Williams, L.; Looker, H.; MacFarlane, D.; Macrury, S.; Malik, I.; McCrimmon, R.; McKeith, D.; McKnight, J.; Mishra, B.; Mukhtar, R.; Mulligan, C.; O’Kane, M.; Olateju, T.; Orpen, I.; Richardson, T.; Rooney, D.; Ross, S.B.; Sathyapalan, T.; Siddaramaiah, N.; Sit, L.E.; Stephens, J.; Turtle, F.; Wakil, A.; Walkinshaw, E.; Ali, A.; Anderson, R.; Arakaki, R.; Aref, O.; Ariani, M.K.; Arkin, D.; Banarer, S.; Barchini, G.; Bhan, A.; Branch, K.; Brautigam, D.; Brietzke, S.; Brinas, M.; Brito, Y.; Carter, C.; Casagni, K.; Casula, S.; Chakko, S.; Charatz, S.; Childress, D.; Chow, L.; Chustecka, M.; Clarke, S.; Cohen, L.; Collins, B.; Colon Vega, G.; Comulada-Rivera, A.; Cortes-Maisonet, G.; Davis, M.; de Souza, J.; Desouza, C.; Dinnan, M.; Duffy-Hidalgo, B.; Dunn, B.; Dunn, J.; Elman, M.; Felicetta, J.; Finkelstein, S.; Fitz-Patrick, D.; Florez, H.; Forker, A.; Fowler, W.; Fredrickson, S.; Freedman, Z.; Gainey Narron, B.; Gainey-Ferree, K.; Gardner, M.; Gastelum, C.; Giddings, S.; Gillespie, E.; Gimness, M.P.; Goldstein, G.; Gomes, M.; Gomez, N.; Gorman, T.; Goswami, K.; Graves, A.; Hacking, S.; Hall, C.; Hanson, L.; Harman, S.; Heber, D.; Henry, R.; Hiner, J.; Hirsch, I.; Hollander, P.; Hooker, T.; Horowitz, B.; Hoste, L.; Huang, L.; Huynh, M.; Hyman, D.; Idriss, S.; Iranmanesh, A.; Karounos, D.; Kashyap, M.; Katz, L.; Kaye, W.; Khaiton, Y.; Khardori, R.; Kitchen, T.; Klein, A.; Knffem, W.; Kosiborod, M.; Kreglinger, N.; Kruger, D.; Kumar, A.; Laboy, I.; Larrabee, P.; Larrick, L.; Lawson, D.; Ledet, M.; Lenhard, J.; Levy, J.; Li, G.; Li, Z.; Lieb, D.; Limcolioc, A.; Lions-Patterson, J.; Lorber, D.; Lorch, D.; Lorrello, M.; Lu, P.; Lucas, K.J.; Ma, S-L.; MacAdams, M.; Magee, M.; Magno, A.; Mahakala, A.R.; Marks, J.; McCall, A.; McClanahan, W., Jr; McClary, C.; Melendez, L.; Melish, J.; Michaud, D.; Miller, C.; Miller, N.; Mora, P.; Moten, M.; Mudaliar, S.; Myrick, G.; Narayan, P.; Nassif, M.; Neri, K.; Newton, T.; Niblack, P.; Nicol, P.; Nyenwe, E.; Odugbesan, A.O.; Okorocha, Y.; Ortiz, C.R.; Osei, K.; Palermo, C.; Patel, H.; Patel, K.; Pau, C.; Perley, M.; Plevin, S.; Plummer, E.; Powell, R.; Qintar, M.; Rawls, R.; Reyes-Castano, J.; Reynolds, L.; Richards, R.; Rosenstock, J.; Rowe, C.; Saleh, J.; Sam, S.; Sanchez, A.; Sander, D.; Sanderson, B.; Savin, V.; Seaquist, E.; Shah, J.; Shi, S.; Shivaswamy, V.; Shlotzhauer, T.; Shore, D.; Skukowski, B.; Soe, K.; Solheim, V.; Soufer, J.; Steinberg, H.; Steinsapir, J.; Tarkington, P.; Thayer, D.; Thomson, S.; Thrasher, J.; Tibaldi, J.; Tjaden, J.; Tores, O.; Trence, D.; Trikudanathan, S.; Ullal, J.; Uwaifo, G.; Vo, A.; Vu, K.; Walia, D.; Weiland, K.; Whitehouse, F.; Wiegmann, T.; Wyne, K.; Wynne, A.; Yuen, K.; Zaretzky, J.; Zebrack, J.; Zieve, F.; Zigrang, W. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): A double-blind, randomised placebo-controlled trial. Lancet, 2019, 394(10193), 121-130.
[http://dx.doi.org/10.1016/S0140-6736(19)31149-3] [PMID: 31189511]
[20]
Marso, S.P.; Bain, S.C.; Consoli, A.; Eliaschewitz, F.G.; Jódar, E.; Leiter, L.A.; Lingvay, I.; Rosenstock, J.; Seufert, J.; Warren, M.L.; Woo, V.; Hansen, O.; Holst, A.G.; Pettersson, J.; Vilsbøll, T. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med., 2016, 375(19), 1834-1844.
[http://dx.doi.org/10.1056/NEJMoa1607141] [PMID: 27633186]
[21]
Marso, S.P.; Daniels, G.H.; Brown-Frandsen, K.; Kristensen, P.; Mann, J.F.E.; Nauck, M.A.; Nissen, S.E.; Pocock, S.; Poulter, N.R.; Ravn, L.S.; Steinberg, W.M.; Stockner, M.; Zinman, B.; Bergenstal, R.M.; Buse, J.B. Liraglutide and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med., 2016, 375(4), 311-322.
[http://dx.doi.org/10.1056/NEJMoa1603827] [PMID: 27295427]
[22]
Takaoka, Y.; Mizuno, A.; Kanie, T.; Yoneoka, D.; Suzuki, T.; Nishikawa, Y.; Tam, W.W.S.; Morze, J.; Rynkiewicz, A.; Xin, Y.; Wu, O. Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: A network meta-analysis. Cochrane Database Syst. Rev., 2021, 10(10), CD013650.
[http://dx.doi.org/10.1002/14651858]
[23]
Raad, M.; López, W.O.C.; Sharafshah, A.; Assefi, M.; Lewandrowski, K.U. Personalized medicine in cancer pain management. J. Pers. Med., 2023, 13(8), 1201.
[http://dx.doi.org/10.3390/jpm13081201] [PMID: 37623452]
[24]
Suchankova, P.; Yan, J.; Schwandt, M.L.; Stangl, B.L.; Caparelli, E.C.; Momenan, R.; Jerlhag, E.; Engel, J.A.; Hodgkinson, C.A.; Egli, M.; Lopez, M.F.; Becker, H.C.; Goldman, D.; Heilig, M.; Ramchandani, V.A.; Leggio, L. The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: Evidence from human genetic association studies and a mouse model of alcohol dependence. Transl. Psychiatry, 2015, 5(6), e583-e583.
[http://dx.doi.org/10.1038/tp.2015.68] [PMID: 26080318]
[25]
Sabaie, H.; Khorami Rouz, S.; Kouchakali, G.; Heydarzadeh, S.; Asadi, M.R.; Sharifi-Bonab, M.; Hussen, B.M.; Taheri, M.; Ayatollahi, S.A.; Rezazadeh, M. Identification of potential regulatory long non-coding RNA-associated competing endogenous RNA axes in periplaque regions in multiple sclerosis. Front. Genet., 2022, 13, 1011350.
[http://dx.doi.org/10.3389/fgene.2022.1011350] [PMID: 36324503]
[26]
Hernandez, N.S.; Weir, V.R.; Ragnini, K.; Merkel, R.; Zhang, Y.; Mace, K.; Rich, M.T.; Christopher, P.R.; Schmidt, H.D. GLP-1 receptor signaling in the laterodorsal tegmental nucleus attenuates cocaine seeking by activating GABAergic circuits that project to the VTA. Mol. Psychiatry, 2021, 26(8), 4394-4408.
[http://dx.doi.org/10.1038/s41380-020-00957-3] [PMID: 33257815]
[27]
Liu, Z.P.; Wu, C.; Miao, H.; Wu, H. RegNetwork: An integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse. Database (Oxford), 2015, 2015, bav095.
[http://dx.doi.org/10.1093/database/bav095] [PMID: 26424082]
[28]
Qiao, L.; Lu, C.; Zang, T.; Dzyuba, B.; Shao, J. Maternal GLP-1 receptor activation inhibits fetal growth. Am. J. Physiol. Endocrinol. Metab., 2024, 326(3), ajpendo.00361.2023.
[http://dx.doi.org/10.1152/ajpendo.00361.2023] [PMID: 38197791]
[29]
Marballi, K.K.; Alganem, K.; Brunwasser, S.J.; Barkatullah, A.; Meyers, K.T.; Campbell, J.M.; Ozols, A.B.; Mccullumsmith, R.E.; Gallitano, A.L. Identification of activity-induced Egr3-dependent genes reveals genes associated with DNA damage response and schizophrenia. Transl. Psychiatry, 2022, 12(1), 320.
[http://dx.doi.org/10.1038/s41398-022-02069-8] [PMID: 35941129]
[30]
Aranäs, C.; Edvardsson, C.E.; Shevchouk, O.T.; Zhang, Q.; Witley, S.; Blid, S.S.; Zentveld, L.; Vallöf, D.; Tufvesson-Alm, M.; Jerlhag, E. Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats. EBioMedicine, 2023, 93, 104642.
[http://dx.doi.org/10.1016/j.ebiom.2023.104642] [PMID: 37295046]
[31]
Fan, X.; Chen, H.; Jiang, F.; Xu, C.; Wang, Y.; Wang, H.; Li, M.; Wei, W.; Song, J.; Zhong, D.; Li, G. Comprehensive analysis of cuproptosis-related genes in immune infiltration in ischemic stroke. Front. Neurol., 2023, 13, 1077178.
[http://dx.doi.org/10.3389/fneur.2022.1077178] [PMID: 36818726]
[32]
Jerlhag, E. The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies. Front. Pharmacol., 2023, 14, 1063033.
[http://dx.doi.org/10.3389/fphar.2023.1063033] [PMID: 37063267]
[33]
Tavares, G.; Rosendo-Silva, D.; Simões, F.; Eickhoff, H.; Marques, D.; Sacramento, J.F.; Capucho, A.M.; Seiça, R.; Conde, S.V.; Matafome, P. Circulating dopamine is regulated by dietary glucose and controls glucagon-like 1 peptide action in white adipose tissue. Int. J. Mol. Sci., 2023, 24(3), 2464.
[http://dx.doi.org/10.3390/ijms24032464] [PMID: 36768789]
[34]
Zhang, L.; Li, C.; Zhang, Z.; Zhang, Z.; Jin, Q.Q.; Li, L.; Hölscher, C. DA5-CH and semaglutide protect against neurodegeneration and reduce α-Synuclein levels in the 6-OHDA parkinson’s disease rat model. Parkinsons Dis., 2022, 2022(1), 1-11.
[http://dx.doi.org/10.1155/2022/1428817] [PMID: 36419409]
[35]
Zhu, C.; Li, H.; Kong, X.; Wang, Y.; Sun, T.; Wang, F. Possible mechanisms underlying the effects of glucagon-like peptide-1 receptor agonist on cocaine use disorder. Front. Pharmacol., 2022, 13, 819470.
[http://dx.doi.org/10.3389/fphar.2022.819470] [PMID: 35300299]
[36]
Konanur, V.R.; Hsu, T.M.; Kanoski, S.E.; Hayes, M.R.; Roitman, M.F. Phasic dopamine responses to a food-predictive cue are suppressed by the glucagon-like peptide-1 receptor agonist Exendin-4. Physiol. Behav., 2020, 215, 112771.
[http://dx.doi.org/10.1016/j.physbeh.2019.112771] [PMID: 31821815]
[37]
Liu, C.; Liu, W.H.; Yang, W.; Chen, L.; Xue, Y.; Chen, X.Y. GLP-1 modulated the firing activity of nigral dopaminergic neurons in both normal and parkinsonian mice. Neuropharmacology, 2024, 252, 109946.
[http://dx.doi.org/10.1016/j.neuropharm.2024.109946] [PMID: 38599494]
[38]
Merkel, R.; Hernandez, N.; Weir, V.; Zhang, Y.; Rich, M.T.; Crist, R.C.; Reiner, B.C.; Schmidt, H.D. An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking. bioRxiv, 2024, 2024.06.
[http://dx.doi.org/10.1101/2024.06.20.599574]
[39]
Fortin, S.M.; Roitman, M.F. Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core. Physiol. Behav., 2017, 176, 17-25.
[http://dx.doi.org/10.1016/j.physbeh.2017.03.019] [PMID: 28315693]
[40]
Reddy, I.A.; Pino, J.A.; Weikop, P.; Osses, N.; Sørensen, G.; Bering, T.; Valle, C.; Bluett, R.J.; Erreger, K.; Wortwein, G.; Reyes, J.G.; Graham, D.; Stanwood, G.D.; Hackett, T.A.; Patel, S.; Fink-Jensen, A.; Torres, G.E.; Galli, A. Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Transl. Psychiatry, 2016, 6(5), e809-e809.
[http://dx.doi.org/10.1038/tp.2016.86] [PMID: 27187231]
[41]
Elasbali, A.M.; Al-Soud, W.A.; Mousa Elayyan, A.E.; Al-Oanzi, Z.H.; Alhassan, H.H.; Mohamed, B.M.; Alanazi, H.H.; Ashraf, M.S.; Moiz, S.; Patel, M.; Patel, M.; Adnan, M. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer. J. Biomol. Struct. Dyn., 2023, 41(23), 14135-14151.
[http://dx.doi.org/10.1080/07391102.2023.2191719] [PMID: 36943780]
[42]
Falk, S.; Petersen, J.; Svendsen, C.; Romero-Leguizamón, C.R.; Jørgensen, S.H.; Krauth, N.; Ludwig, M.Q.; Lundø, K.; Roostalu, U.; Skovbjerg, G.; Nielsen, D.A.G.; Ejdrup, A.L.; Pers, T.H.; Dmytriyeva, O.; Hecksher-Sørensen, J.; Gether, U.; Kohlmeier, K.A.; Clemmensen, C. GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity. Cell Rep., 2023, 42(5), 112466.
[http://dx.doi.org/10.1016/j.celrep.2023.112466] [PMID: 37148870]
[43]
Borsook, D.; Linnman, C.; Faria, V.; Strassman, A.M.; Becerra, L.; Elman, I. Reward deficiency and anti-reward in pain chronification. Neurosci. Biobehav. Rev., 2016, 68, 282-297.
[http://dx.doi.org/10.1016/j.neubiorev.2016.05.033] [PMID: 27246519]
[44]
Blum, K.; McLaughlin, T.; Bowirrat, A.; Modestino, E.J.; Baron, D.; Gomez, L.L.; Ceccanti, M.; Braverman, E.R.; Thanos, P.K.; Cadet, J.L.; Elman, I.; Badgaiyan, R.D.; Jalali, R.; Green, R.; Simpatico, T.A.; Gupta, A.; Gold, M.S. Reward deficiency syndrome (RDS) surprisingly is evolutionary and found everywhere: Is it “blowin’in the wind”? J. Pers. Med., 2022, 12(2), 321.
[http://dx.doi.org/10.3390/jpm12020321] [PMID: 35207809]
[45]
Gruber, J.; Hanssen, R.; Qubad, M.; Bouzouina, A.; Schack, V.; Sochor, H.; Schiweck, C.; Aichholzer, M.; Matura, S.; Slattery, D.A.; Zopf, Y.; Borgland, S.L.; Reif, A.; Thanarajah, S.E. Impact of insulin and insulin resistance on brain dopamine signalling and reward processing – An underexplored mechanism in the pathophysiology of depression? Neurosci. Biobehav. Rev., 2023, 149, 105179.
[http://dx.doi.org/10.1016/j.neubiorev.2023.105179] [PMID: 37059404]
[46]
Gondré-Lewis, M.C.; Bassey, R.; Blum, K. Pre-clinical models of reward deficiency syndrome: A behavioral octopus. Neurosci. Biobehav. Rev., 2020, 115, 164-188.
[http://dx.doi.org/10.1016/j.neubiorev.2020.04.021] [PMID: 32360413]
[47]
Wilson, J.B.; Epstein, M.; Lopez, B.; Brown, A.K.; Lutfy, K.; Friedman, T.C. The role of neurochemicals, stress hormones and immune system in the positive feedback loops between diabetes, obesity and depression. Front. Endocrinol. (Lausanne), 2023, 14, 1224612.
[http://dx.doi.org/10.3389/fendo.2023.1224612] [PMID: 37664841]
[48]
Elman, I.; Borsook, D.; Volkow, N.D. Pain and suicidality: Insights from reward and addiction neuroscience. Prog. Neurobiol., 2013, 109, 1-27.
[http://dx.doi.org/10.1016/j.pneurobio.2013.06.003] [PMID: 23827972]
[49]
Blum, K.; Blum, K.; Febo, M.; Baron, D.; Modestino, E.J.; Elman, I.; Badgaiyan, R.D. Molecular role of dopamine in anhedonia linked to reward deficiency syndrome RDS and anti- reward systems. Front. Biosci. (Schol. Ed.), 2018, 10(2), 309-325.
[http://dx.doi.org/10.2741/s518] [PMID: 29293435]
[50]
Nephew, B.; Murgatroyd, C.; Pittet, F.; Febo, M. Brain reward pathway dysfunction in maternal depression and addiction: A present and future transgenerational risk. J. Reward Defic. Syndr., 2015, 1(3), 105-116.
[http://dx.doi.org/10.17756/jrds.2015-017] [PMID: 27617302]
[51]
Arango-Lievano, M.; Kaplitt, M.G. Comorbidity between depression and addiction-Towards a common molecular target? Med. Sci., 2015, 3(5), 546-550.
[52]
Zhao, X.; Wu, S.; Li, X.; Liu, Z.; Lu, W.; Lin, K.; Shao, R. Common neural deficits across reward functions in major depression: A meta-analysis of fMRI studies. Psychol. Med., 2024, 54(11), 2794-2806.
[http://dx.doi.org/10.1017/S0033291724001235] [PMID: 38777630]
[53]
Must, A.; Szabó, Z.; Bódi, N.; Szász, A.; Janka, Z.; Kéri, S. Sensitivity to reward and punishment and the prefrontal cortex in major depression. J. Affect. Disord., 2006, 90(2-3), 209-215.
[http://dx.doi.org/10.1016/j.jad.2005.12.005] [PMID: 16412520]
[54]
Salamone, J.D.; Correa, M.; Yohn, S.; Lopez Cruz, L.; San Miguel, N.; Alatorre, L. The pharmacology of effort-related choice behavior: Dopamine, depression, and individual differences. Behav. Processes, 2016, 127, 3-17.
[http://dx.doi.org/10.1016/j.beproc.2016.02.008] [PMID: 26899746]
[55]
Park, I.H.; Lee, B.C.; Kim, J.J.; Kim, J.I.; Koo, M.S. Effort-based reinforcement processing and functional connectivity underlying amotivation in medicated patients with depression and schizophrenia. J. Neurosci., 2017, 37(16), 4370-4380.
[http://dx.doi.org/10.1523/JNEUROSCI.2524-16.2017] [PMID: 28283562]
[56]
Sapuram, V.R.; Vrshek-Schallhorn, S.; Hilt, L.M.; Stroud, C.B. Dopaminergic genetic variation in young adolescents: Associations with sensation-seeking. Res. Child Adolesc. Psychopathol., 2021, 49(10), 1259-1274.
[http://dx.doi.org/10.1007/s10802-021-00823-y] [PMID: 33963956]
[57]
Bergamini, G.; Sigrist, H.; Ferger, B.; Singewald, N.; Seifritz, E.; Pryce, C.R. Depletion of nucleus accumbens dopamine leads to impaired reward and aversion processing in mice: Relevance to motivation pathologies. Neuropharmacology, 2016, 109, 306-319.
[http://dx.doi.org/10.1016/j.neuropharm.2016.03.048] [PMID: 27036890]
[58]
Lutz, P.E.; Kieffer, B.L. Opioid receptors: Distinct roles in mood disorders. Trends Neurosci., 2013, 36(3), 195-206.
[http://dx.doi.org/10.1016/j.tins.2012.11.002] [PMID: 23219016]
[59]
Wolters, E.C.; van der Werf, Y.D.; van den Heuvel, O.A. Parkinson’s disease-related disorders in the impulsive-compulsive spectrum. J. Neurol., 2008, 255(S5)(Suppl. 5), 48-56.
[http://dx.doi.org/10.1007/s00415-008-5010-5] [PMID: 18787882]
[60]
Thanos, P.K.; Blum, K.; McCarthy, M.; Senior, D.; Watts, S.; Connor, C.; Hammond, N.; Hadjiargyrou, M.; Komatsu, D.; Steiner, H. Combined chronic oral methylphenidate and fluoxetine treatment during adolescence: Effects on behavior. Curr. Pharm. Biotechnol., 2023, 24(10), 1307-1314.
[http://dx.doi.org/10.2174/1389201024666221028092342] [PMID: 36306463]
[61]
Rothman, R.B.; Blough, B.E.; Baumann, M.H. Dual dopamine/serotonin releasers as potential medications for stimulante and alcohol addictions. AAPS J., 2007, 9(1), E1-E10.
[http://dx.doi.org/10.1208/aapsj0901001] [PMID: 17408232]
[62]
Ribeiro, G.; Maia, A.; Cotovio, G.; Oliveira, F.P.M.; Costa, D.C.; Oliveira-Maia, A.J. Striatal dopamine D2-like receptors availability in obesity and its modulation by bariatric surgery: A systematic review and meta-analysis. Sci. Rep., 2023, 13(1), 4959.
[http://dx.doi.org/10.1038/s41598-023-31250-2] [PMID: 36973321]
[63]
Kanoski, S.E.; Hayes, M.R.; Skibicka, K.P. GLP-1 and weight loss: Unraveling the diverse neural circuitry. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2016, 310(10), R885-R895.
[http://dx.doi.org/10.1152/ajpregu.00520.2015] [PMID: 27030669]
[64]
Yorgason, J.T.; Wadsworth, H.A.; Anderson, E.J.; Williams, B.M.; Brundage, J.N.; Hedges, D.M.; Stockard, A.L.; Jones, S.T.; Arthur, S.B.; Hansen, D.M.; Schilaty, N.D.; Jang, E.Y.; Lee, A.M.; Wallner, M.; Steffensen, S.C. Modulation of dopamine release by ethanol is mediated by atypical GABAA receptors on cholinergic interneurons in the nucleus accumbens. Addict. Biol., 2022, 27(1), e13108.
[http://dx.doi.org/10.1111/adb.13108] [PMID: 34713509]
[65]
EMA statement on ongoing review of GLP-1 receptor agonists. 2023. Available from : https://www.ema.europa.eu/en/news/ema-statement-ongoing-review-glp-1-receptor-agonists
[66]
Terhune, R.R.C. Wegovy, other weight-loss drugs scrutinized over reports of suicidal thoughts., 2023. Available from: https://www.reuters.com/business/healthcare-pharmaceuticals/wegovy-other-weight-loss-drugs-scrutinized-over-reports-suicidal-thoughts-2023-09-28/
[67]
Ruggiero, R.; Mascolo, A.; Spezzaferri, A.; Carpentieri, C.; Torella, D.; Sportiello, L.; Rossi, F.; Paolisso, G.; Capuano, A. Glucagon-like Peptide-1 receptor agonists and suicidal ideation: Analysis of real-word data collected in the European Pharmacovigilance database. Pharmaceuticals, 2024, 17(2), 147.
[http://dx.doi.org/10.3390/ph17020147] [PMID: 38399362]
[68]
Tobaiqy, M.; Elkout, H. Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: A pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database. Int. J. Clin. Pharm., 2024, 46(2), 488-495.
[http://dx.doi.org/10.1007/s11096-023-01694-7] [PMID: 38265519]
[69]
Maideen, N.M.P.; Al Rashid, S. Suicidal thoughts and self-injurious behavior associated with glucagon-like peptide-1 receptor agonists - A review. Curr. Drug Saf., 2024, 19.
[http://dx.doi.org/10.2174/0115748863301925240507044637] [PMID: 38766830]
[70]
Salvo, F.; Faillie, J.L. GLP-1 receptor agonists and suicidality—caution is needed. JAMA Netw. Open, 2024, 7(8), e2423335-e2423335.
[http://dx.doi.org/10.1001/jamanetworkopen.2024.23335] [PMID: 39163050]
[71]
Driggin, E.; Goyal, P. Malnutrition and Sarcopenia as reasons for caution with GLP-1 receptor agonist use in HFpEF. J. Card. Fail., 2024, 30(4), 610-612.
[http://dx.doi.org/10.1016/j.cardfail.2024.01.005] [PMID: 38301742]
[72]
Scheen, A.J. Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists. Diabetes Metab., 2022, 48(6), 101390.
[http://dx.doi.org/10.1016/j.diabet.2022.101390] [PMID: 36170946]
[73]
Leehey, D.J.; Rahman, M.A.; Borys, E.; Picken, M.M.; Clise, C.E. Acute kidney injury associated with semaglutide. Kidney Med., 2021, 3(2), 282-285.
[http://dx.doi.org/10.1016/j.xkme.2020.10.008] [PMID: 33851124]
[74]
Sun, Y.; Fan, L.; Meng, J.; Zhang, F.; Zhang, D.; Mei, Q. Should GLP-1 receptor agonists be used with caution in high risk population for colorectal cancer? Med. Hypotheses, 2014, 82(3), 255-256.
[http://dx.doi.org/10.1016/j.mehy.2013.11.034] [PMID: 24424394]
[75]
Borab, Z.M.; Fisher, S.M.; Borab, Z.M.; Gimenez, A.; Raskin, P.; Valek, T.; Rohrich, R.J. Emerging role of Semaglutide and GLP-1 agonist medications in plastic surgery: A note of caution. Plast. Reconstr. Surg., 2021, 154(3), 629-631.
[http://dx.doi.org/10.1097/PRS.0000000000011418]
[76]
Nohara, H.; Nakashima, R.; Kamei, S.; Fujikawa, H.; Ueno-Shuto, K.; Kawakami, T.; Eto, Y.; Suico, M.A.; Li, J.D.; Kai, H.; Shuto, T. Intratracheal GLP-1 receptor agonist treatment up-regulates mucin via p38 and exacerbates emphysematous phenotype in mucus hypersecretory obstructive lung diseases. Biochem. Biophys. Res. Commun., 2020, 524(2), 332-339.
[http://dx.doi.org/10.1016/j.bbrc.2020.01.081] [PMID: 31996306]
[77]
Nguyen, A.; Smith, E.; Hashemy, H.; Agarwal, S.M.; Hahn, M.K.; Paterson, A.D.; Dash, S. Glucagon‐like‐peptide 1 receptor agonism and attempted suicide: A Mendelian randomisation study to assess a potential causal association. Clin. Obes., 2024, 14(4), e12676.
[http://dx.doi.org/10.1111/cob.12676] [PMID: 38778795]
[78]
Zhou, J.; Zheng, Y.; Xu, B.; Long, S.; Zhu, L.; Liu, Y.; Li, C.; Zhang, Y.; Liu, M.; Wu, X. Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: A pharmacovigilance study based on the FDA Adverse Event Reporting System database. BMC Med., 2024, 22(1), 65.
[http://dx.doi.org/10.1186/s12916-024-03274-6] [PMID: 38355513]
[79]
Wang, W.; Volkow, N.D.; Berger, N.A.; Davis, P.B.; Kaelber, D.C.; Xu, R. Association of semaglutide with risk of suicidal ideation in a real-world cohort. Nat. Med., 2024, 30(1), 168-176.
[http://dx.doi.org/10.1038/s41591-023-02672-2] [PMID: 38182782]
[80]
Aschenbrenner, D.S. Preliminary review finds no link between GLP-1 receptor agonists and suicidality. Am. J. Nurs., 2024, 124(5), 20.
[http://dx.doi.org/10.1097/01.NAJ.0001016352.54091.a1] [PMID: 38661695]
[81]
Plum, L.; Belgardt, B.F.; Brüning, J.C. Central insulin action in energy and glucose homeostasis. J. Clin. Invest., 2006, 116(7), 1761-1766.
[http://dx.doi.org/10.1172/JCI29063] [PMID: 16823473]
[82]
Patti, M.E.; Butte, A.J.; Crunkhorn, S.; Cusi, K.; Berria, R.; Kashyap, S.; Miyazaki, Y.; Kohane, I.; Costello, M.; Saccone, R.; Landaker, E.J.; Goldfine, A.B.; Mun, E.; DeFronzo, R.; Finlayson, J.; Kahn, C.R.; Mandarino, L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA, 2003, 100(14), 8466-8471.
[http://dx.doi.org/10.1073/pnas.1032913100] [PMID: 12832613]
[83]
Gardner, A.; Boles, R.G. Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2011, 35(3), 730-743.
[http://dx.doi.org/10.1016/j.pnpbp.2010.07.030] [PMID: 20691744]
[84]
Agarwal, S.M.; Caravaggio, F.; Costa-Dookhan, K.A.; Castellani, L.; Kowalchuk, C.; Asgariroozbehani, R.; Graff-Guerrero, A.; Hahn, M. Brain insulin action in schizophrenia: Something borrowed and something new. Neuropharmacology, 2020, 163, 107633.
[http://dx.doi.org/10.1016/j.neuropharm.2019.05.010] [PMID: 31077731]
[85]
Nag, M. Effect of chlorpromazine, imipramine and lithium on MAO-A and MAO-B activity in rat brain mitochondria. Indian J. Exp. Biol., 2004, 42(9), 941-944.
[PMID: 15462192]
[86]
Herculano-Houzel, S. The glia/neuron ratio: How it varies uniformly across brain structures and species and what that means for brain physiology and evolution. Glia, 2014, 62(9), 1377-1391.
[http://dx.doi.org/10.1002/glia.22683] [PMID: 24807023]
[87]
Kleinridders, A.; Cai, W.; Cappellucci, L.; Ghazarian, A.; Collins, W.R.; Vienberg, S.G.; Pothos, E.N.; Kahn, C.R. Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc. Natl. Acad. Sci. USA, 2015, 112(11), 3463-3468.
[http://dx.doi.org/10.1073/pnas.1500877112] [PMID: 25733901]
[88]
Stuart, M.J.; Baune, B.T. Depression and type 2 diabetes: Inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci. Biobehav. Rev., 2012, 36(1), 658-676.
[http://dx.doi.org/10.1016/j.neubiorev.2011.10.001] [PMID: 22020230]
[89]
Sadek, M.A.; Kandil, E.A.; El Sayed, N.S.; Sayed, H.M.; Rabie, M.A. Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3β pathway. Int. Immunopharmacol., 2023, 115, 109647.
[http://dx.doi.org/10.1016/j.intimp.2022.109647] [PMID: 36584570]
[90]
Schoretsanitis, G.; Weiler, S.; Barbui, C.; Raschi, E.; Gastaldon, C. Disproportionality analysis from World Health Organization data on semaglutide, liraglutide, and suicidality. JAMA Netw. Open, 2024, 7(8), e2423385-e2423385.
[http://dx.doi.org/10.1001/jamanetworkopen.2024.23385] [PMID: 39163046]
[91]
Blum, K.; Madigan, M.A.; Fuehrlein, B.; Thanos, P.K.; Lewandrowski, K.U.; Sharafshah, A.; Elman, I.; Baron, D.; Bowirrat, A.; Pinhasov, A.; Braverman, E.R.; Zeine, F.; Jafari, N.; Gold, M.S. Genes and Genetic Testing in Addiction Medicine., 2024. https://www.sciencedirect.com/referencework/9780128093245/reference-module-in-neuroscience-and-biobehavioral-psychology eferenceModule in Neuroscience and Biobehavioral Psychology
[92]
Tobaiqy, M.; Elkout, H. Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: A pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database. Int. J. Clin. Pharm., 2024, 46(2), 488-495.
[http://dx.doi.org/10.1007/s11096-023-01694-7] [PMID: 38265519]
[93]
Chen, W.; Cai, P.; Zou, W.; Fu, Z. Psychiatric adverse events associated with GLP-1 receptor agonists: A real-world pharmacovigilance study based on the FDA Adverse event reporting system database. Front. Endocrinol. (Lausanne), 2024, 15, 1330936.
[http://dx.doi.org/10.3389/fendo.2024.1330936] [PMID: 38390214]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy